angiotensin ii, des-phe(8)- has been researched along with Lung Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, L; Feng, Y; Gao, B; Li, Q; Ma, Q; Ni, L; Qian, Y; Wan, H; Xiang, Y | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and Lung Adenocarcinoma
Article | Year |
---|---|
Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Angiotensin I; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Renin-Angiotensin System; Signal Transduction; Survival | 2012 |